The pharmaceutical industry is racing to meet demand for GLP-1 weight-loss drugs, such as Ozempic and Mounjaro, a market that JPMorgan forecasts will reach $200 billion by 2030. Meanwhile, the antibiotics...

We spent $4.6 trillion fighting covid-19. Meanwhile, antibiotic-resistant bacteria killed 1.27 million people in 2019 alone — more than HIV or malaria individually, and we’ve invested significantly...